AbbVie Seeks at Least $8 Billion in Debt to Fund Apogee Deal

AbbVie Inc. is seeking to raise at least $8 billion from an investment-grade bond offering to fund a portion of its acquisition of Apogee Therapeutics Inc.

By Brian Smith and Michael Gambale · Bloomberg Markets

AbbVie Inc. is seeking to raise at least $8 billion from an investment-grade bond offering to fund a portion of its acquisition of Apogee Therapeutics Inc.